{"entity":{"type":"insider","cik":"0001847941","url":"/insider/0001847941","json_url":"/insider/0001847941.json","name":"Farwell Wildon","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":15,"first":"2022-03-03","last":"2024-08-20","span_basis":"filed_date"},"name_variants":[{"name":"Farwell Wildon","source":"filing","n_filings":15,"first_seen":"2022-03-03","last_seen":"2024-08-20"}],"transactions":[{"id":2897546,"accession":"0000950170-24-099125","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-099125","line_url":"/filing/0000950170-24-099125","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2321.0,"shares_display":"2,321","price_per_share":45.12132701421801,"price_display":"45.12","price_state":"stated","total_value":104726.6,"total_display":"104,726.60","total_whole":"104,727","shares_owned_after":143483.0,"shares_owned_after_display":"143,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-08-19","filed_date":"2024-08-20","scope":"insider","n_lines":2},{"id":2304801,"accession":"0000950170-24-072168","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-072168","line_url":"/filing/0000950170-24-072168","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2636.0,"shares_display":"2,636","price_per_share":31.27,"price_display":"31.27","price_state":"stated","total_value":82427.72,"total_display":"82,427.72","total_whole":"82,428","shares_owned_after":146551.0,"shares_owned_after_display":"146,551","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-11","scope":"insider","n_lines":2},{"id":2984347,"accession":"0000950170-24-062079","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-062079","line_url":"/filing/0000950170-24-062079","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2381.0,"shares_display":"2,381","price_per_share":28.269613607727845,"price_display":"28.27","price_state":"stated","total_value":67309.95,"total_display":"67,309.95","total_whole":"67,310","shares_owned_after":148604.0,"shares_owned_after_display":"148,604","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-16","filed_date":"2024-05-17","scope":"insider","n_lines":2},{"id":2341890,"accession":"0000950170-24-030483","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-030483","line_url":"/filing/0000950170-24-030483#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1030.0,"shares_display":"1,030","price_per_share":25.58,"price_display":"25.58","price_state":"stated","total_value":26347.4,"total_display":"26,347.40","total_whole":"26,347","shares_owned_after":150560.0,"shares_owned_after_display":"150,560","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-12","filed_date":"2024-03-12","scope":"insider"},{"id":2341884,"accession":"0000950170-24-030483","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-030483","line_url":"/filing/0000950170-24-030483#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1585.0,"shares_display":"1,585","price_per_share":25.7,"price_display":"25.70","price_state":"stated","total_value":40734.5,"total_display":"40,734.50","total_whole":"40,735","shares_owned_after":151590.0,"shares_owned_after_display":"151,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-11","filed_date":"2024-03-12","scope":"insider"},{"id":2949187,"accession":"0000950170-24-029609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-029609","line_url":"/filing/0000950170-24-029609","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9921.0,"shares_display":"9,921","price_per_share":25.86277592984578,"price_display":"25.86","price_state":"stated","total_value":256584.6,"total_display":"256,584.60","total_whole":"256,585","shares_owned_after":154732.0,"shares_owned_after_display":"154,732","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-07","filed_date":"2024-03-11","scope":"insider","n_lines":2},{"id":2674366,"accession":"0000950170-24-022242","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-022242","line_url":"/filing/0000950170-24-022242#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":407.0,"shares_display":"407","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":10175.0,"total_display":"10,175.00","total_whole":"10,175","shares_owned_after":163096.0,"shares_owned_after_display":"163,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-28","filed_date":"2024-02-28","scope":"insider"},{"id":2634376,"accession":"0000950170-24-015259","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-015259","line_url":"/filing/0000950170-24-015259#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5493.0,"shares_display":"5,493","price_per_share":25.07,"price_display":"25.07","price_state":"stated","total_value":137709.51,"total_display":"137,709.51","total_whole":"137,710","shares_owned_after":163503.0,"shares_owned_after_display":"163,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-12","filed_date":"2024-02-14","scope":"insider"},{"id":2302221,"accession":"0000950170-24-008063","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-008063","line_url":"/filing/0000950170-24-008063#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":2500.0,"total_display":"2,500.00","total_whole":"2,500","shares_owned_after":168996.0,"shares_owned_after_display":"168,996","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-26","filed_date":"2024-01-26","scope":"insider"},{"id":8585600,"accession":"0001209191-23-058328","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-058328","line_url":"/filing/0001209191-23-058328#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":978.0,"shares_display":"978","price_per_share":10.55,"price_display":"10.55","price_state":"stated","total_value":10317.9,"total_display":"10,317.90","total_whole":"10,318","shares_owned_after":169096.0,"shares_owned_after_display":"169,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-12","filed_date":"2023-12-12","scope":"insider"},{"id":8585597,"accession":"0001209191-23-058328","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-058328","line_url":"/filing/0001209191-23-058328#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1688.0,"shares_display":"1,688","price_per_share":10.72,"price_display":"10.72","price_state":"stated","total_value":18095.36,"total_display":"18,095.36","total_whole":"18,095","shares_owned_after":170074.0,"shares_owned_after_display":"170,074","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-12-11","filed_date":"2023-12-12","scope":"insider"},{"id":8116711,"accession":"0001209191-23-049362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-049362","line_url":"/filing/0001209191-23-049362#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1707.0,"shares_display":"1,707","price_per_share":10.41,"price_display":"10.41","price_state":"stated","total_value":17769.87,"total_display":"17,769.87","total_whole":"17,770","shares_owned_after":89250.0,"shares_owned_after_display":"89,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-12","filed_date":"2023-09-13","scope":"insider"},{"id":8112797,"accession":"0001209191-23-037165","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-037165","line_url":"/filing/0001209191-23-037165#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1698.0,"shares_display":"1,698","price_per_share":12.43,"price_display":"12.43","price_state":"stated","total_value":21106.14,"total_display":"21,106.14","total_whole":"21,106","shares_owned_after":90957.0,"shares_owned_after_display":"90,957","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-13","filed_date":"2023-06-14","scope":"insider"},{"id":7831599,"accession":"0001209191-23-018979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-23-018979","line_url":"/filing/0001209191-23-018979#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7441.0,"shares_display":"7,441","price_per_share":13.33,"price_display":"13.33","price_state":"stated","total_value":99188.53,"total_display":"99,188.53","total_whole":"99,189","shares_owned_after":92655.0,"shares_owned_after_display":"92,655","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-03-14","filed_date":"2023-03-15","scope":"insider"},{"id":6575350,"accession":"0001209191-22-060969","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-060969","line_url":"/filing/0001209191-22-060969#line-2","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":628.0,"shares_display":"628","price_per_share":10.87,"price_display":"10.87","price_state":"stated","total_value":6826.36,"total_display":"6,826.36","total_whole":"6,826","shares_owned_after":100096.0,"shares_owned_after_display":"100,096","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-12","filed_date":"2022-12-13","scope":"insider"},{"id":6542840,"accession":"0001209191-22-018533","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-018533","line_url":"/filing/0001209191-22-018533#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":640.0,"shares_display":"640","price_per_share":8.73,"price_display":"8.73","price_state":"stated","total_value":5587.2,"total_display":"5,587.20","total_whole":"5,587","shares_owned_after":66050.0,"shares_owned_after_display":"66,050","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-14","scope":"insider"},{"id":6097224,"accession":"0001209191-22-015901","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-015901","line_url":"/filing/0001209191-22-015901#line-1","is_derivative":false,"issuer_cik":"0001818794","issuer_name":"Dyne Therapeutics, Inc.","issuer_ticker":"DYN","issuer_name_source":null,"issuer_url":"/issuer/0001818794","owner_cik":"0001847941","owner_name":"Farwell Wildon","owner_display_name":"Farwell Wildon","owner_url":"/insider/0001847941","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5617.0,"shares_display":"5,617","price_per_share":8.56,"price_display":"8.56","price_state":"stated","total_value":48081.52,"total_display":"48,081.52","total_whole":"48,082","shares_owned_after":66690.0,"shares_owned_after_display":"66,690","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-02","filed_date":"2022-03-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":21,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001818794","name":"Dyne Therapeutics, Inc.","url":"/issuer/0001818794","role":"Officer (Chief Medical Officer)","n_filings":15,"first_seen":"2022-03-03","last_seen":"2024-08-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001847941","retrieved_at":"2026-08-27T08:31:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}